Filtros de búsqueda

Lista de obras de Lennart Minthon

18F-flutemetamol amyloid imaging in Alzheimer disease and mild cognitive impairment: a phase 2 trial

artículo científico publicado en 2010

1st Conference Clinical Trials on Alzheimer’s Disease September 17-18-19, 2008 School of Medecine Montpellier, France

article

A Genetic Variant of the Sortilin 1 Gene is Associated with Reduced Risk of Alzheimer's Disease

artículo científico publicado en 2016

A Quick Test for Cognitive Speed: a measure of cognitive speed in dementia with Lewy bodies.

artículo científico publicado en 2007

A Quick Test of cognitive speed is sensitive in detecting early treatment response in Alzheimer's disease

artículo científico publicado en 2010

A longitudinal study of physical function in patients with early-onset dementia

artículo científico publicado en 2012

A longitudinal study of risk factors for community-based home help services in Alzheimer's disease: the influence of cholinesterase inhibitor therapy

artículo científico publicado en 2013

A new automated method for analysis of rCBF-SPECT images based on the active-shape algorithm: normal values

artículo científico publicado en 2011

A novel ARC gene polymorphism is associated with reduced risk of Alzheimer's disease

artículo científico publicado en 2012

A novel ARC polymorphism is associated with reduced risk of Alzheimer's disease

scholarly article by Petronella Kettunen et al published July 2010 in Alzheimer's and Dementia

A selected reaction monitoring (SRM)-based method for absolute quantification of Aβ38, Aβ40, and Aβ42 in cerebrospinal fluid of Alzheimer's disease patients and healthy controls.

artículo científico publicado en 2013

Accuracy of a panel of 5 cerebrospinal fluid biomarkers in the differential diagnosis of patients with dementia and/or parkinsonian disorders

artículo científico publicado en 2012

Accuracy of brain amyloid detection in clinical practice using cerebrospinal fluid β-amyloid 42: a cross-validation study against amyloid positron emission tomography

artículo científico publicado en 2014

Alterations of matrix metalloproteinases in the healthy elderly with increased risk of prodromal Alzheimer's disease

artículo científico publicado en 2010

Altered CSF orexin and α-synuclein levels in dementia patients

artículo científico publicado en 2012

Altered chemokine levels in the cerebrospinal fluid and plasma of suicide attempters

artículo científico publicado en 2012

Amyloid-β oligomers in cerebrospinal fluid are associated with cognitive decline in patients with Alzheimer's disease

artículo científico publicado en 2012

An integrated workflow for multiplex CSF proteomics and peptidomics-identification of candidate cerebrospinal fluid biomarkers of Alzheimer's disease

artículo científico publicado en 2014

Antihypertensive therapy is associated with reduced rate of conversion to Alzheimer's disease in midregional proatrial natriuretic peptide stratified subjects with mild cognitive impairment

artículo científico publicado en 2011

Apolipoprotein E genotype and the diagnostic accuracy of cerebrospinal fluid biomarkers for Alzheimer disease

artículo científico publicado en 2014

Assessment of kallikrein 6 as a cross-sectional and longitudinal biomarker for Alzheimer's disease

artículo científico publicado en 2018

Assessment of peptide chemical modifications on the development of an accurate and precise multiplex selected reaction monitoring assay for apolipoprotein e isoforms

artículo científico publicado en 2014

Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up study

artículo científico publicado en 2006

Association between white matter hyperintensities and executive decline in mild cognitive impairment is network dependent

artículo científico publicado en 2010

Association of complement factor H Y402H gene polymorphism with Alzheimer's disease

artículo científico publicado en 2008

Association of the RAGE G82S polymorphism with Alzheimer's disease

artículo científico publicado en 2010

Associations between AQT processing speed and neuropsychological tests in neuropsychiatric patients.

artículo científico publicado en 2007

Automatic temporal lobe atrophy assessment in prodromal AD: Data from the DESCRIPA study

artículo científico publicado en 2013

Aβ40 oligomers identified as a potential biomarker for the diagnosis of Alzheimer's disease

artículo científico publicado en 2010

BACE1 gene variants do not influence BACE1 activity, levels of APP or Aβ isoforms in CSF in Alzheimer's disease

artículo científico publicado en 2010

Binary classification of ¹⁸F-flutemetamol PET using machine learning: comparison with visual reads and structural MRI.

artículo científico publicado en 2012

Body mass index is associated with biological CSF markers of core brain pathology of Alzheimer's disease

artículo científico publicado en 2011

Both total and phosphorylated tau are increased in Alzheimer's disease

artículo científico publicado en 2001

C4b-binding protein in Alzheimer's disease: Binding to Aβ1–42 and to dead cells

artículo científico publicado en 2008

CCL2 is associated with a faster rate of cognitive decline during early stages of Alzheimer's disease

artículo científico publicado en 2012

CSF Aβ42/Aβ40 and Aβ42/Aβ38 ratios: better diagnostic markers of Alzheimer disease

artículo científico publicado en 2016

CSF Mg and Ca as diagnostic markers for dementia with Lewy bodies.

artículo científico publicado en 2008

CSF amyloid β38 as a novel diagnostic marker for dementia with Lewy bodies.

artículo científico publicado en 2010

CSF biomarkers and incipient Alzheimer disease in patients with mild cognitive impairment.

artículo científico publicado en 2009

CSF biomarkers correlate with cerebral blood flow on SPECT in healthy elderly

artículo científico publicado en 2012

CSF biomarkers for Alzheimer's Disease: levels of beta-amyloid, tau, phosphorylated tau relate to clinical symptoms and survival

artículo científico publicado en 2006

CSF biomarkers for Alzheimer's pathology and the effect size of APOE ɛ4.

artículo científico publicado en 2013

CSF biomarkers for the differential diagnosis of Alzheimer's disease: A large-scale international multicenter study.

artículo científico publicado en 2015

CSF biomarkers predict a more malignant outcome in Alzheimer disease.

artículo científico publicado en 2010

CSF levels of tau, beta-amyloid(1-42) and GAP-43 in frontotemporal dementia, other types of dementia and normal aging

artículo científico publicado en 2000

Can CSF biomarkers or pre-treatment progression rate predict response to cholinesterase inhibitor treatment in Alzheimer's disease?

artículo científico publicado en 2009

Cerebral Microbleeds and White Matter Hyperintensities in Cognitively Healthy Elderly: A Cross-Sectional Cohort Study Evaluating the Effect of Arterial Stiffness

artículo científico publicado en 2015

Cerebral pattern of pro- and anti-inflammatory cytokines in dementias

artículo científico publicado en 2003

Cerebral white matter lesions - associations with Aβ isoforms and amyloid PET

artículo científico publicado en 2016

Cerebrospinal Fluid Levels of sAPPα and sAPPβ in Lewy Body and Alzheimer's Disease: Clinical and Neurochemical Correlates

artículo científico

Cerebrospinal fluid beta-amyloid(1-42) in Alzheimer disease: differences between early- and late-onset Alzheimer disease and stability during the course of disease.

artículo científico publicado en 1999

Cerebrospinal fluid biomarker results in relation to neuropathological dementia diagnoses

artículo científico publicado en 2010

Cerebrospinal fluid biomarkers predict decline in subjective cognitive function over 3 years in healthy elderly.

artículo científico publicado en 2007

Cerebrospinal fluid levels of IL-6 are decreased and correlate with cognitive status in DLB patients

artículo científico publicado en 2015

Cerebrospinal fluid levels of biomarkers and activity of acetylcholinesterase (AChE) and butyrylcholinesterase in AD patients before and after treatment with different AChE inhibitors.

artículo científico publicado en 2002

Cerebrospinal fluid levels of complement proteins C3, C4 and CR1 in Alzheimer’s disease

article

Cerebrospinal fluid levels of heart fatty acid binding protein are elevated prodromally in Alzheimer's disease and vascular dementia

artículo científico publicado en 2013

Cerebrospinal fluid levels of the synaptic protein neurogranin correlates with cognitive decline in prodromal Alzheimer's disease

artículo científico publicado en 2014

Cerebrospinal fluid levels of β-amyloid 1-42, but not of tau, are fully changed already 5 to 10 years before the onset of Alzheimer dementia

artículo científico publicado en 2012

Cerebrospinal fluid profiles of amyloid β-related biomarkers in Alzheimer's disease

artículo científico publicado en 2012

Cerebrospinal fluid tau and Abeta42 as predictors of development of Alzheimer's disease in patients with mild cognitive impairment

scientific article published on 01 September 1999

Cerebrospinal fluid tau and beta-amyloid(1-42) in dementia disorders

artículo científico publicado en 2001

Cerebrospinal fluid total tau as a marker of Alzheimer's disease intensity.

artículo científico publicado en 2010

Cerebrospinal fluid total tau is associated with shorter survival in dementia with Lewy bodies.

artículo científico publicado en 2009

Cerebrospinal fluid/plasma quotients of essential and non-essential metals in patients with Alzheimer's disease.

artículo científico publicado en 2011

Changes in CSF acetyl- and butyrylcholinesterase activity after long-term treatment with AChE inhibitors in Alzheimer's disease.

artículo científico publicado en 2010

Changes in cerebrospinal fluid and blood plasma levels of IGF-II and its binding proteins in Alzheimer's disease: an observational study

artículo científico publicado en 2014

Changes in cognitive domains during three years in patients with Alzheimer's disease treated with donepezil

artículo científico publicado en 2009

Changes in the activity and protein levels of CSF acetylcholinesterases in relation to cognitive function of patients with mild Alzheimer's disease following chronic donepezil treatment.

artículo científico publicado en 2006

Characterization of the postsynaptic protein neurogranin in paired cerebrospinal fluid and plasma samples from Alzheimer's disease patients and healthy controls

artículo científico publicado en 2015

Cholinesterase inhibitors do not alter the length of stay in nursing homes among patients with Alzheimer's disease: a prospective, observational study of factors affecting survival time from admission to death

artículo científico publicado en 2016

Classification and prediction of clinical Alzheimer's diagnosis based on plasma signaling proteins

artículo científico publicado en 2007

Clinical utility of color-form naming in Alzheimer's disease: preliminary evidence.

artículo científico publicado en 2004

Cognitive impairment is undetected in medical inpatients: a study of mortality and recognition amongst healthcare professionals

artículo científico publicado en 2012

Combined rCBF and CSF biomarkers predict progression from mild cognitive impairment to Alzheimer's disease

artículo científico publicado en 2007

Comparison of brief cognitive tests and CSF biomarkers in predicting Alzheimer's disease in mild cognitive impairment: six-year follow-up study

artículo científico publicado en 2012

Complement gene single nucleotide polymorphisms and biomarker endophenotypes of Alzheimer's disease

artículo científico publicado en 2013

Computerized cognition assessment during acetylcholinesterase inhibitor treatment in Alzheimer's disease

artículo científico publicado en 2009

Concentrations of metals, beta-amyloid and tau-markers in cerebrospinal fluid in patients with Alzheimer's disease

artículo científico publicado en 2009

Confounding factors influencing amyloid Beta concentration in cerebrospinal fluid

artículo científico publicado en 2010

Copeptin, a Marker of Vasopressin, Predicts Vascular Dementia but not Alzheimer's Disease

artículo científico publicado en 2016

Correlation between clinical characteristics and cerebrospinal fluid neuropeptide Y levels in dementia of the Alzheimer type and frontotemporal dementia

artículo científico publicado en 1996

Correlation of longitudinal cerebrospinal fluid biomarkers with cognitive decline in healthy older adults.

artículo científico publicado en 2010

Cortical blood flow during head-up postural change in subjects with orthostatic hypotension

artículo científico publicado en 1993

Cube copying test in combination with rCBF or CSF A beta 42 predicts development of Alzheimer's disease

artículo científico publicado en 2008

Cystatin C Levels are Positively Correlated with both Aβ42 and Tau Levels in Cerebrospinal Fluid in Persons with Alzheimer's Disease, Mild Cognitive Impairment, and Healthy Controls

scholarly article by Johan Sundelöf et al published 11 August 2010 in Journal of Alzheimer's Disease

Cytoskeleton proteins in CSF distinguish frontotemporal dementia from AD

artículo científico publicado en 2000

Decreased levels of intrathecal interleukin 1 receptor antagonist in Alzheimer's disease

artículo científico publicado en 2001

Decreased monoamine metabolites in frontotemporal dementia and Alzheimer's disease

artículo científico publicado en 1998

Descriptive study and pharmacotherapeutic intervention in patients with epilepsy or Parkinson's disease at nursing homes in southern Sweden

artículo científico publicado en 2002

Detailed comparison of amyloid PET and CSF biomarkers for identifying early Alzheimer disease

artículo científico publicado en 2015

Development of screening guidelines and clinical criteria for predementia Alzheimer's disease. The DESCRIPA Study.

artículo científico publicado en 2008

Diabetes mellitus and elevated copeptin levels in middle age predict low cognitive speed after long-term follow-up

artículo científico publicado en 2013

Diagnosis-independent Alzheimer disease biomarker signature in cognitively normal elderly people

artículo científico publicado en 2010

Diagnostic power of 24S-hydroxycholesterol in cerebrospinal fluid: candidate marker of brain health

artículo científico publicado en 2013

Differences in survival between patients with dementia with Lewy bodies and patients with Alzheimer's disease--measured from a fixed cognitive level

artículo científico publicado en 2011

Differential increase in cerebrospinal fluid-acetylcholinesterase after treatment with acetylcholinesterase inhibitors in patients with Alzheimer's disease

artículo científico publicado en 2001

Disease progression and costs of care in Alzheimer's disease patients treated with donepezil: a longitudinal naturalistic cohort

artículo científico publicado en 2011

Donepezil in Alzheimer's disease: what to expect after 3 years of treatment in a routine clinical setting.

artículo científico publicado en 2006

Donepezil in patients with severe Alzheimer's disease: double-blind, parallel-group, placebo-controlled study.

artículo científico publicado en 2006

Effects of Alzheimer's peptide and α1-antichymotrypsin on astrocyte gene expression

article

Efficacy of memantine in PDD and DLB: an extension study including washout and open-label treatment

artículo científico publicado en 2011

Electroencephalogram variability in dementia with lewy bodies, Alzheimer's disease and controls.

artículo científico publicado en 2008

Elevated cerebrospinal fluid BACE1 activity in incipient Alzheimer disease

artículo científico publicado en 2008

Elevated plasma levels of soluble CD40 in incipient Alzheimer's disease.

artículo científico publicado en 2008

Evaluating amyloid-β oligomers in cerebrospinal fluid as a biomarker for Alzheimer's disease

artículo científico publicado en 2013

Evaluation of CSF Biomarkers as Predictors of Alzheimer's Disease: A Clinical Follow-Up Study of 4.7 Years

scholarly article by Joakim Hertze et al published 10 September 2010 in Journal of Alzheimer's Disease

Evaluation of CSF biomarkers as predictors of Alzheimer's disease: a clinical follow-up study of 4.7 years

artículo científico publicado en 2010

Evaluation of CSF-tau and CSF-Abeta42 as diagnostic markers for Alzheimer disease in clinical practice

artículo científico publicado en 2001

Evaluation of a previously suggested plasma biomarker panel to identify Alzheimer's disease

artículo científico publicado en 2012

Evaluation of plasma Abeta(40) and Abeta(42) as predictors of conversion to Alzheimer's disease in patients with mild cognitive impairment

artículo científico publicado en 2008

Evaluation of the cerebrospinal fluid amyloid-β1-42/amyloid-β1-40 ratio measured by alpha-LISA to distinguish Alzheimer's disease from other dementia disorders

artículo científico publicado en 2013

Evolution of Abeta42 and Abeta40 levels and Abeta42/Abeta40 ratio in plasma during progression of Alzheimer's disease: a multicenter assessment

artículo científico publicado en 2009

Five-year outcome of cholinergic treatment of Alzheimer's disease: early response predicts prolonged time until nursing home placement, but does not alter life expectancy

artículo científico publicado en 2004

Functional mannose-binding lectin haplotype variants are associated with Alzheimer's disease

artículo científico publicado en 2013

Functional response to cholinesterase inhibitor therapy in a naturalistic Alzheimer's disease cohort

artículo científico publicado en 2012

Galantamine treatment in Alzheimer's disease: response and long-term outcome in a routine clinical setting

artículo científico publicado en 2011

Gender-dependent levels of hyaluronic acid in cerebrospinal fluid of patients with neurodegenerative dementia

artículo científico publicado en 2012

Genetic association of CDC2 with cerebrospinal fluid tau in Alzheimer's disease.

artículo científico publicado en 2005

Genetic variants of GSK3B are associated with biomarkers for Alzheimer's disease and cognitive function

artículo científico publicado en 2015

Genome-wide association study identifies four novel loci associated with Alzheimer's endophenotypes and disease modifiers

artículo científico publicado en 2017

Genome-wide, high-content siRNA screening identifies the Alzheimer's genetic risk factor FERMT2 as a major modulator of APP metabolism

artículo científico publicado en 2016

Higher Cathepsin B Levels in Plasma in Alzheimer's Disease Compared to Healthy Controls

scholarly article by Johan Sundelöf et al published 7 January 2011 in Journal of Alzheimer's Disease

Identification of CSF biomarkers for frontotemporal dementia using SELDI-TOF.

artículo científico publicado en 2005

Identification of SPARC-like 1 protein as part of a biomarker panel for Alzheimer's disease in cerebrospinal fluid

artículo científico publicado en 2012

Identification of a novel panel of cerebrospinal fluid biomarkers for Alzheimer's disease.

artículo científico publicado en 2007

Importance and added value of functional impairment to predict mortality: a cohort study in Swedish medical inpatients

artículo científico publicado en 2017

Increased amyloidogenic APP processing in APOE ɛ4-negative individuals with cerebral β-amyloidosis

artículo científico publicado en 2016

Increased frequency of a new polymorphism in the cell division cycle 2 (cdc2) gene in patients with Alzheimer's disease and frontotemporal dementia

article

Increased levels of hyaluronic acid in cerebrospinal fluid in patients with vascular dementia

artículo científico publicado en 2014

Inflammatory markers in matched plasma and cerebrospinal fluid from patients with Alzheimer's disease

artículo científico publicado en 2003

Injury markers predict time to dementia in subjects with MCI and amyloid pathology

artículo científico publicado en 2012

Kinesin gene variability may affect tau phosphorylation in early Alzheimer's disease

artículo científico publicado en 2007

Kinesin light chain 1 gene haplotypes in three conformational diseases.

artículo científico publicado en 2009

Kynurenic Acid levels in cerebrospinal fluid from patients with Alzheimer's disease or dementia with lewy bodies

artículo científico publicado en 2014

Lack of orthostatic symptoms in dementia patients with orthostatic hypotension

artículo científico publicado en 2014

Levels of cerebrospinal fluid α-synuclein oligomers are increased in Parkinson's disease with dementia and dementia with Lewy bodies compared to Alzheimer's disease

artículo científico publicado en 2014

Long-term Outcome and Prediction Models of Activities of Daily Living in Alzheimer Disease With Cholinesterase Inhibitor Treatment ⬇️

artículo científico publicado el 1 de enero de 2011

Long-term effects of tacrine on regional cerebral blood flow changes in Alzheimer's disease

scientific article published on 01 September 1995

Long-term rivastigmine treatment in a routine clinical setting

artículo científico publicado en 2008

Longitudinal Associations between Survival in Alzheimer's Disease and Cholinesterase Inhibitor Use, Progression, and Community-Based Services

artículo científico publicado en 2015

Longitudinal cerebrospinal fluid biomarker measurements in preclinical sporadic Alzheimer's disease: A prospective 9-year study

artículo científico publicado en 2015

Longitudinal stability evaluation of biomarkers and their correlation in cerebrospinal fluid and plasma from patients with Alzheimer's disease.

artículo científico publicado en 2012

Longitudinal stability of CSF biomarkers in Alzheimer's disease.

artículo científico publicado en 2007

Longitudinal study of CSF biomarkers in patients with Alzheimer's disease

artículo científico publicado en 2009

Low CSF levels of both α-synuclein and the α-synuclein cleaving enzyme neurosin in patients with synucleinopathy

artículo científico publicado en 2013

Low incidence of post-lumbar puncture headache in 1,089 consecutive memory clinic patients

artículo científico publicado en 2010

Low levels of soluble NG2 in cerebrospinal fluid from patients with dementia with Lewy bodies

artículo científico publicado en 2014

Measurement of alpha- and beta-secretase cleaved amyloid precursor protein in cerebrospinal fluid from Alzheimer patients

artículo científico publicado en 2003

Measurement of apolipoprotein E (apoE) in cerebrospinal fluid

artículo científico publicado en 2000

Measurements of medial temporal lobe atrophy for prediction of Alzheimer's disease in subjects with mild cognitive impairment

artículo científico publicado en 2013

Medial temporal lobe atrophy increases the specificity of cerebrospinal fluid biomarkers in Alzheimer disease with minor cerebrovascular changes

artículo científico publicado en 2009

Medial temporal lobe atrophy is underreported and may have important clinical correlates in medical inpatients

artículo científico publicado en 2015

Metal concentrations in plasma and cerebrospinal fluid in patients with Alzheimer's disease.

artículo científico publicado en 2008

Microglial markers are elevated in the prodromal phase of Alzheimer's disease and vascular dementia.

artículo científico publicado en 2013

Mild versus moderate stages of Alzheimer's disease: three-year outcomes in a routine clinical setting of cholinesterase inhibitor therapy

artículo científico publicado en 2016

Modern dementia care on the rise thanks to national guidelines

artículo científico publicado en 2013

Monte Carlo feature selection and rule-based models to predict Alzheimer's disease in mild cognitive impairment

artículo científico publicado en 2012

Multidisciplinary intervention reducing readmissions in medical inpatients: a prospective, non-randomized study

artículo científico publicado en 2013

Multiple rapid automatic naming measures of cognition: normal performance and effects of aging.

artículo científico publicado en 2004

Myo-inositol changes precede amyloid pathology and relate to APOE genotype in Alzheimer disease

artículo científico publicado en 2016

NG2 cells, a new trail for Alzheimer's disease mechanisms?

artículo científico publicado en 2013

Neurogranin in cerebrospinal fluid as a marker of synaptic degeneration in Alzheimer's disease.

artículo científico publicado en 2010

Neuropeptide levels in Alzheimer's disease and dementia with frontotemporal degeneration

artículo científico publicado en 1990

Neuropeptides in cerebrospinal fluid of patients with Alzheimer's disease and dementia with frontotemporal lobe degeneration.

artículo científico publicado en 1993

No association between the α2-macroglobulin (A2M) deletion and Alzheimer's disease, and no change in A2M mRNA, protein, or protein expression

scholarly article by Kaj Blennow et al published 11 August 2000 in Journal of Neural Transmission

No association of LOXL1 gene polymorphisms with Alzheimer's disease.

artículo científico publicado en 2011

No association of VEGF polymorphims with Alzheimer's disease.

artículo científico publicado en 2009

No diagnostic value of plasma clusterin in Alzheimer's disease

artículo científico publicado en 2012

No independent association between pulse wave velocity and dementia: a population-based, prospective study

artículo científico publicado en 2017

Nonlinear association between pulse wave velocity and cognitive function: a population-based study

artículo científico publicado en 2014

Novel panel of cerebrospinal fluid biomarkers for the prediction of progression to Alzheimer dementia in patients with mild cognitive impairment

artículo científico publicado en 2007

Nrf2-encoding NFE2L2 haplotypes influence disease progression but not risk in Alzheimer's disease and age-related cataract.

artículo científico publicado en 2010

Oral tetrahydroaminoacridine treatment of Alzheimer's disease evaluated clinically and by regional cerebral blood flow and EEG.

artículo científico publicado en 1993

Parietal lobe activation in rapid, automatized naming by adults

artículo científico

Patients with Lewy body dementia use more resources than those with Alzheimer's disease

artículo científico publicado en 2007

Patients with dementia with lewy bodies have more impaired quality of life than patients with Alzheimer disease.

artículo científico publicado en 2007

Performance and complications of lumbar puncture in memory clinics: Results of the multicenter lumbar puncture feasibility study

artículo científico publicado en 2015

Performance of middle-aged and elderly European minority and majority populations on a Cross-Cultural Neuropsychological Test Battery (CNTB).

artículo científico publicado en 2018

Plasma and CSF serpins in Alzheimer disease and dementia with Lewy bodies.

artículo científico publicado en 2007

Plasma levels of 24S-hydroxycholesterol in patients with neurological diseases.

artículo científico publicado en 2000

Plasma tau levels in Alzheimer's disease

artículo científico publicado en 2013

Practical suggestions on how to differentiate dementia with Lewy bodies from Alzheimer's disease with common cognitive tests

artículo científico publicado en 2009

Preclinical effects of APOE ε4 on cerebrospinal fluid Aβ42 concentrations

artículo científico publicado en 2017

Predicting long-term cognitive outcome with new regression models in donepezil-treated Alzheimer patients in a naturalistic setting

artículo científico publicado en 2008

Predicting progression from cognitive impairment to Alzheimer's disease with the Disease State Index

artículo científico publicado en 2015

Prediction of Alzheimer disease in subjects with amnestic and nonamnestic MCI.

artículo científico publicado en 2013

Prediction of Alzheimer's disease using a cerebrospinal fluid pattern of C-terminally truncated beta-amyloid peptides

artículo científico publicado en 2008

Prediction of Alzheimer's disease using midregional proadrenomedullin and midregional proatrial natriuretic peptide: a retrospective analysis of 134 patients with mild cognitive impairment

artículo científico publicado en 2010

Prediction of Alzheimer's disease using the CSF Abeta42/Abeta40 ratio in patients with mild cognitive impairment.

artículo científico publicado en 2007

Predictors of long-term cognitive outcome in Alzheimer's disease

artículo científico publicado en 2011

Prevalence and prognostic value of CSF markers of Alzheimer's disease pathology in patients with subjective cognitive impairment or mild cognitive impairment in the DESCRIPA study: a prospective cohort study.

artículo científico publicado en 2009

Prevalence of Dementia With Lewy Body Symptoms: A Cross-Sectional Study in 40 Swedish Nursing Homes

artículo científico publicado en 2016

Processing of neuropeptide Y, galanin, and somatostatin in the cerebrospinal fluid of patients with Alzheimer's disease and frontotemporal dementia

artículo científico publicado en 2001

Progression of mild Alzheimer's disease: knowledge and prediction models required for future treatment strategies

artículo científico publicado en 2013

Quality of life and the effect of memantine in dementia with lewy bodies and Parkinson's disease dementia

artículo científico publicado en 2011

Redistribution of blood flow in the cerebral cortex of normal subjects during head-up postural change

artículo científico publicado en 1992

Reference measurement procedure for CSF amyloid beta (Aβ)1-42 and the CSF Aβ1-42 /Aβ1-40 ratio - a cross-validation study against amyloid PET.

artículo científico publicado en 2016

Regional cerebral blood flow in Alzheimer's disease: classification and analysis of heterogeneity

artículo científico publicado en 2004

Reliability, validity and clinical correlates of the Quality of Life in Alzheimer’s disease (QoL-AD) scale in medical inpatients

artículo científico publicado en 2016

Response to cholinesterase inhibitors affects lifespan in Alzheimer's disease

artículo científico publicado en 2014

Response to the Letter From Abid Iraqi, MD, CMD and Terry Hughes, RN, CS.

artículo científico publicado en 2017

Risk factors for nursing home placement in Alzheimer's disease: a longitudinal study of cognition, ADL, service utilization, and cholinesterase inhibitor treatment

artículo científico publicado en 2010

Risk factors that affect life expectancy in Alzheimer's disease: a 15-year follow-up

artículo científico publicado en 2014

SNAP-25 is a promising novel cerebrospinal fluid biomarker for synapse degeneration in Alzheimer's disease

artículo científico publicado en 2014

Safety, tolerability, and antibody response of active Aβ immunotherapy with CAD106 in patients with Alzheimer's disease: randomised, double-blind, placebo-controlled, first-in-human study

artículo científico publicado en 2012

Sensitivity, specificity, and stability of CSF-tau in AD in a community-based patient sample.

artículo científico publicado en 1999

Sex-specific genetic predictors of Alzheimer's disease biomarkers

artículo científico publicado en 2018

Short-Term Response to Cholinesterase Inhibitors in Alzheimer's Disease Delays Time to Nursing Home Placement.

artículo científico publicado en 2018

Single-domain amnestic mild cognitive impairment identified by cluster analysis predicts Alzheimer's disease in the european prospective DESCRIPA study

artículo científico publicado en 2013

Slowing of EEG correlates with CSF biomarkers and reduced cognitive speed in elderly with normal cognition over 4 years

article

Solitary living in Alzheimer's disease over 3 years: association between cognitive and functional impairment and community-based services

artículo científico publicado en 2014

Soluble TNF receptors are associated with Aβ metabolism and conversion to dementia in subjects with mild cognitive impairment

artículo científico publicado en 2010

Soluble adhesion molecules and angiotensin-converting enzyme in dementia

artículo científico publicado en 2007

Soluble amyloid precursor protein α and β in CSF in Alzheimer's disease

artículo científico publicado en 2013

Somatostatin and neuropeptide Y in cerebrospinal fluid: correlations with severity of disease and clinical signs in Alzheimer's disease and frontotemporal dementia

artículo científico publicado en 1997

Standardization of measurement of beta-amyloid(1-42) in cerebrospinal fluid and plasma

artículo científico publicado en 2000

TNF gene polymorphism and its relation to intracerebral production of TNFalpha and TNFbeta in AD.

artículo científico publicado en 2000

Tacrine and rate of progression in Alzheimer's disease--relation to ApoE allele genotype

artículo científico publicado en 2001

Tacrine may alter APP-like protein levels in the lumbar CSF of Alzheimer patients

artículo científico publicado en 2001

Tacrine treatment modifies cerebrospinal fluid neuropeptide levels in Alzheimer's disease.

artículo científico publicado en 1994

Tau pathology and parietal white matter lesions have independent but synergistic effects on early development of Alzheimer's disease

artículo científico publicado en 2013

Test sequence of CSF and MRI biomarkers for prediction of AD in subjects with MCI.

artículo científico publicado en 2012

The Inflammatory Marker YKL-40 Is Elevated in Cerebrospinal Fluid from Patients with Alzheimer's but Not Parkinson's Disease or Dementia with Lewy Bodies

artículo científico publicado en 2015

The Montreal Cognitive Assessment: Normative Data from a Large Swedish Population-Based Cohort

artículo científico

The PPAR-alpha gene in Alzheimer's disease: lack of replication of earlier association

scientific article published on 11 September 2007

The apolipoprotein E epsilon4 allele frequency is normal in fronto-temporal dementia, but correlates with age at onset of disease

artículo científico publicado en 1997

The association between APOE ε4 and Alzheimer-type dementia among memory clinic patients is confined to those with a higher education. The DESCRIPA Study

artículo científico publicado en 2013

The cerebrospinal fluid "Alzheimer profile": easily said, but what does it mean?

artículo científico publicado en 2014

The cognitive profile and CSF biomarkers in dementia with Lewy bodies and Parkinson's disease dementia ⬇️

artículo científico publicado el 1 de enero de 2011

The effect of memantine on sleep behaviour in dementia with Lewy bodies and Parkinson's disease dementia

artículo científico publicado en 2010

The impact of autonomic dysfunction on survival in patients with dementia with Lewy bodies and Parkinson's disease with dementia

artículo científico publicado en 2012

The period of hypotension following orthostatic challenge is prolonged in dementia with Lewy bodies

scientific article published on 01 February 2008

The stability of AQT processing speed, ADAS-Cog and MMSE during acetylcholinesterase inhibitor treatment in Alzheimer's disease.

artículo científico publicado en 2009

The transcobalamin (TC) codon 259 genetic polymorphism influences holo-TC concentration in cerebrospinal fluid from patients with Alzheimer disease

scientific journal article

The transcobalamin 776C > G polymorphism may be a modifiable genetic risk factor for Alzheimer's disease

artículo científico publicado en 2005

The usefulness of cube copying for evaluating treatment of Alzheimer's disease.

artículo científico publicado en 2008

There is a strong evidence that professional boxing results in chronic brain damage. The more head punches during a boxer's career, the bigger is the risk

artículo científico publicado en 2005

Total apolipoprotein E levels and specific isoform composition in cerebrospinal fluid and plasma from Alzheimer's disease patients and controls

artículo científico publicado en 2014

Treatment effect of memantine on survival in dementia with Lewy bodies and Parkinson's disease with dementia: a prospective study

artículo científico publicado en 2014

Ubiquitin carboxy-terminal hydrolase L1 (UCHL1) S18Y polymorphism in Alzheimer's disease

artículo científico publicado en 2010

Ubiquitin carboxyl-terminal esterase L1 (UCHL1) S18Y polymorphism in patients with cataracts ⬇️

artículo científico publicado en 2011

Use of Flutemetamol F 18-Labeled Positron Emission Tomography and Other Biomarkers to Assess Risk of Clinical Progression in Patients With Amnestic Mild Cognitive Impairment

article by David A Wolk et al published 1 September 2018 in JAMA Neurology

Usefulness of computed tomography linear measurements in diagnosing Alzheimer's disease.

artículo científico publicado en 2008

Vagus nerve stimulation in patients with Alzheimer's disease: Additional follow-up results of a pilot study through 1 year.

artículo científico publicado en 2006

White matter hyperintensities and medial temporal lobe atrophy in clinical subtypes of mild cognitive impairment: the DESCRIPA study

artículo científico publicado en 2009

[About mice and men. Not certain that findings in mice with Alzheimer disease can be applied in clinical reality]

scientific article published on 01 December 2006

[New discoveries on Alzheimer disease: new biochemical markers can hopefully improve diagnosis]

artículo científico publicado en 2000

α-synuclein antibodies recognize a protein present at lower levels in the CSF of patients with dementia with Lewy bodies

scholarly article by Clive Ballard et al published 14 September 2009 in International Psychogeriatrics

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda